Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Carcinogenesis

• Publication date

  1993-08-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1093/CARCIN/14.8.1633PMID 8353847
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sequences and expression of alleles of polymorphic arylamine N-acetyltransferase of human liver.

  1992cited by this paper
• N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells.

  1992cited by this paper
• Salmonella typhimurium strains expressing human arylamine N-acetyltransferases: metabolism and mutagenic activation of aromatic amines.

  1992cited by this paper
• Site-directed mutagenesis of recombinant human arylamine N-acetyltransferase expressed in Escherichia coli. Evidence for direct involvement of Cys68 in the catalytic mechanism of polymorphic human NAT2.

  1992cited by this paper
• Metabolism and nucleic acid binding of N-hydroxy-4-acetylaminobiphenyl and N-acetoxy-4-acetylaminobiphenyl by cultured human uroepithelial cells.

  1992cited by this paper
• Diverse point mutations in the human gene for polymorphic N-acetyltransferase.

  1991cited by this paper
• Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct.

  1991cited by this paper
• Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon.

  1991cited by this paper
• Polymorphic and monomorphic expression of arylamine carcinogen N-acetyltransferase isozymes in tumor target organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus.

  1991cited by this paper
• Molecular mechanism of slow acetylation of drugs and carcinogens in humans.

  1991cited by this paper
• Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.

  1991cited by this paper
• Monomorphic and polymorphic isozymes of arylamine N-acetyltransferases in hamster liver: purification of the isozymes and genetic basis of N-acetylation polymorphism.

  1990cited by this paper
• Purification of hepatic polymorphic arylamine N-acetyltransferase from homozygous rapid acetylator inbred hamster: identity with polymorphic N-hydroxyarylamine-O-acetyltransferase.

  1990cited by this paper
• Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.

  1990cited by this paper
• Correlation between acetylator phenotypes and genotypes of polymorphic arylamine N-acetyltransferase in human liver.

  1990cited by this paper
• Acetylator genotype-dependent expression of arylamine N-acetyltransferase and N-hydroxyarylamine O-acetyltransferase in Syrian inbred hamster intestine and colon. Identity with the hepatic acetylation polymorphism.

  1990cited by this paper
• Human Arylamine N-Acetyltransferase Genes: Isolation, Chromosomal Localization, and Functional Expression

  1990cited by this paper
• Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver.

  1990cited by this paper
• Kinetic characterization of acetylator genotype-dependent and -independent N-acetyltransferase isozymes in homozygous rapid and slow acetylator inbred hamster liver cytosol.

  1989cited by this paper
• Purification and biochemical characterization of hepatic arylamine N-acetyltransferase from rapid and slow acetylator mice: identity with arylhydroxamic acid N,O-acyltransferase and N-hydroxyarylamine O-acetyltransferase.

  1989cited by this paper
• Metabolism of aromatic amines: relationships of N-acetylation, O-acetylation, N,O-acetyltransfer and deacetylation in human liver and urinary bladder.

  1989cited by this paper
• Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines.

  1989cited by this paper
• Genetic polymorphism and cancer susceptibility: Evidence concerning acetyltransferases and cancer of the urinary bladder

  1988cited by this paper
• Acetylator genotype and arylamine-induced carcinogenesis.

  1988cited by this paper
• Acetylation phenotype in colorectal carcinoma.

  1987cited by this paper
• Acetylator genotype-dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: relationship to arylamine N-acetyltransferase.

  1987cited by this paper
• Inheritance of acetylator genotype-dependent arylamine N-acetyltransferase in hamster bladder cytosol.

  1987cited by this paper
• Acetyl coenzyme A dependent activation of N-hydroxy derivatives of carcinogenic arylamines: mechanism of activation, species difference, tissue distribution, and acetyl donor specificity.

  1986cited by this paper
• Role of aromatic amine acetyltransferase in human colorectal cancer.

  1986cited by this paper
• Detection of 2-amino-3-methylimidazo[4,5-f]quinoline in cigarette smoke condensate.

  1986cited by this paper
• Acetyl coenzyme A-dependent metabolic activation of N-hydroxy-3,2'-dimethyl-4-aminobiphenyl and several carcinogenic N-hydroxy arylamines in relation to tissue and species differences, other acyl donors, and arylhydroxamic acid-dependent acyltransferases.

  1986cited by this paper
• N-acetylation pharmacogenetics.

  1985cited by this paper
• Mutagens-carcinogens in foods.

  1983cited by this paper
• Historical and modern epidemiological studies on populations exposed to N-substituted aryl compounds.

  1983cited by this paper
• Relationship between nucleic acid adduct formation and deacylation of arylhydroxamic acids.

  1983cited by this paper
• Evidence that arylhydroxamic acid N,O-acyltransferase and the genetically polymorphic N-acetyltransferase are properties of the same enzyme in rabbit liver.

  1980cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• Mechanism of reaction, tissue distribution, and inhibition of arylhydroxamic acid acyltransferase.

  1974cited by this paper

• Pharmacogenomic heterogeneity of N-acetyltransferase 2: a comprehensive analysis of real world data in Indian tuberculosis patients and from literature and database review

  2025cites this paper
• Human xenobiotic metabolism proteins have full-length and split homologs in the gut microbiome

  2025cites this paper
• Synergizing Machine Learning, Conceptual Density Functional Theory, and Biochemistry: No-Code Explainable Predictive Models for Mutagenicity in Aromatic Amines

  2024cites this paper
• NAT1 inhibits liver metastasis of colorectal cancer by regulating EMT and glycolysis

  2024cites this paper
• First report on a series of food-derived mutagenic and carcinogenic heterocyclic amines

  2024cites this paper
• Human xenobiotic metabolism proteins have full-length and split homologs in the gut microbiome

  2024cites this paper
• The effect of the rs1799931 G857A (G286E) polymorphism on N-acetyltransferase 2-mediated carcinogen metabolism and genotoxicity differs with heterocyclic amine exposure

  2023cites this paper
• 560G>A (rs4986782) (R187Q) Single Nucleotide Polymorphism in Arylamine N-Acetyltransferase 1 Increases Affinity for the Aromatic Amine Carcinogens 4-Aminobiphenyl and N-Hydroxy-4-Aminobiphenyl: Implications for Cancer Risk Assessment

  2022cites this paper
• Human Arylamine N-Acetyltransferase 1 (NAT1) Knockout in MDA-MB-231 Breast Cancer Cell Lines Leads to Transcription of NAT2

  2022influential citation
• Expression of arylamine N-acetyltransferase 2 activity in immortalized human bronchial epithelial cells.

  2022cites this paper
• Editorial: Insights in Pharmacogenetics and Pharmacogenomics: 2021

  2022cites this paper
• Human N-Acetyltransferase 1 and 2 Differ in Affinity Towards Acetyl-Coenzyme A Cofactor and N-Hydroxy-Arylamine Carcinogens

  2022cites this paper
• N-acetyltransferase 2 acetylator genotype-dependent N-acetylation and toxicity of the arylamine carcinogen β-naphthylamine in cryopreserved human hepatocytes

  2022cites this paper
• Association of N-acetyltransferases 1 and 2 Polymorphisms with Susceptibility to Head and Neck Cancers—A Meta-Analysis, Meta-Regression, and Trial Sequential Analysis

  2021cites this paper
• Identification and characterization of potent, selective, and efficacious inhibitors of human arylamine N-acetyltransferase 1

  2021cites this paper
• Human arylamine N-acetyltransferase 2 genotype-dependent protein expression in cryopreserved human hepatocytes

  2020cites this paper
• Acetylation of putative arylamine and alkylaniline carcinogens in immortalized human fibroblasts transfected with rapid and slow acetylator N-acetyltransferase 2 haplotypes

  2020cites this paper
• N-acetyltransferase: the practical consequences of polymorphic activity in man

  2020cites this paper
• Acetylation

  2020cites this paper
• Lung Cancer: Genetic Susceptibility

  2020cites this paper
• Primary aromatic amines and cancer: Novel mechanistic insights using 4-aminobiphenyl as a model carcinogen.

  2019cites this paper
• Probing the Effect of Bulky Lesion-Induced Replication Fork Conformational Heterogeneity Using 4-Aminobiphenyl-Modified DNA

  2019cites this paper
• DNA Damage, Repair, and Mutational Spectrum

  2019cites this paper
• Effect of 2-acetylaminofluorene and its genotoxic metabolites on DNA adduct formation and DNA damage in 3D reconstructed human skin tissue models

  2019cites this paper
• Mucosal 5‐aminosalicylic acid concentration, drug formulation and mucosal microbiome in patients with quiescent ulcerative colitis

  2019cites this paper
• N-acetyltransferase 2 acetylator genotype-dependent N-acetylation of 4-aminobiphenyl in cryopreserved human hepatocytes

  2019cites this paper
• Molecular Biomarkers and Urinary Bladder Cancer (UBC)

  2019cites this paper
• Role of the human N-acetyltransferase 2 genetic polymorphism in metabolism and genotoxicity of 4, 4′-methylenedianiline

  2019cites this paper
• Bioactivation mechanisms of N‐hydroxyaristolactams: Nitroreduction metabolites of aristolochic acids

  2019cites this paper
• Genetic polymorphisms in the drug detoxification genes and susceptibility to Urinary Bladder Cancer (UBC)

  2018influential citation
• Knockout of human arylamine N‐acetyltransferase 1 (NAT1) in MDA‐MB‐231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity

  2018cites this paper
• Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models

  2018cites this paper
• Deciphering the role of human arylamine N-acetyltransferase 1 (NAT1) in breast cancer cell metabolism using a systems biology approach.

  2018cites this paper
• Highlight report: gene dose response in N-acetylation capacity

  2017cites this paper
• Genetic heterogeneity among slow acetylator N-acetyltransferase 2 phenotypes in cryopreserved human hepatocytes

  2017cites this paper
• Intégrer les échelles moléculaires et cellulaires dans l'inférence de réseaux métaboliques : application aux xénobiotiques. (Integrate molecular and cellular scales in the inference of metabolic networks : application to xenobiotics)

  2017cites this paper
• Gut microbiome interactions with drug metabolism, efficacy, and toxicity.

  2017cites this paper
• Arylamine N-acetyltransferase 1 in situ N-acetylation on CD3+ peripheral blood mononuclear cells correlate with NATb mRNA and NAT1 haplotype

  2017cites this paper
• Association of N-acetyltransferase 1 Polymorphism and Bladder Cancer Risk: An Updated Meta-analysis and Trial Sequential Analysis

  2017cites this paper
• In Silico Screening and Analysis of Potential Inhibitors of Arylamine N-Acetyltransferases (NATs) from the Traditional Chinese Medicine: A Study Using Free Available Tools

  2017cites this paper
• Biotransformation of 2,4-toluenediamine in human skin and reconstructed tissues

  2017cites this paper
• Association Between NAT2 Polymorphisms and Prostate Cancer

  2017cites this paper
• Role of human arylamine n-acetyltransferase 1 in tumorigenesis and cancer biology.

  2017cites this paper
• Classification of carcinogenic and mutagenic properties using machine learning method

  2017cites this paper
• Catalytic properties and heat stabilities of novel recombinant human N-acetyltransferase 2 allozymes support existence of genetic heterogeneity within the slow acetylator phenotype

  2017cites this paper
• Translesion Synthesis of the N2-2′-Deoxyguanosine Adduct of the Dietary Mutagen IQ in Human Cells: Error-Free Replication by DNA Polymerase κ and Mutagenic Bypass by DNA Polymerases η, ζ, and Rev1

  2016cites this paper
• The Modulation of Drug Efficacy and Toxicity by the Gut Microbiome

  2015cites this paper
• Human arylamine n-acetyltransferase 1: pursuit of an endogenous role

  2015cites this paper
• Folate-dependent hydrolysis of acetyl-coenzyme A by recombinant human and rodent arylamine N-acetyltransferases

  2015cites this paper
• Gene–environment interactions in esophageal cancer

  2015cites this paper
• DNA polymerases κ and ζ cooperatively perform mutagenic translesion synthesis of the C8–2′-deoxyguanosine adduct of the dietary mutagen IQ in human cells

  2015cites this paper
• Base-Displaced Intercalated Conformation of the 2-Amino-3-methylimidazo[4,5-f]quinoline N2-dG DNA Adduct Positioned at the Nonreiterated G1 in the NarI Restriction Site

  2015cites this paper
• Thiopurine metabolites variations during co-treatment with aminosalicylates for inflammatory bowel disease: effect of N-acetyl transferase polymorphisms.

  2015cites this paper
• N-acetyltransferase 1 and 2 polymorphisms and risk of diabetes mellitus type 2 in a Saudi population

  2015cites this paper
• Biomonitoring of human exposure to arylamines.

  2015cites this paper
• Ultraviolet A radiation potentiates the cytotoxic and genotoxic effects of 7 H‐dibenzo[c,g]carbazole and its methyl derivatives

  2015cites this paper
• N-acetylation of aromatic amines: implication for skin and immune cells.

  2015cites this paper
• Mechanisms of 4-aminobiphenyl-induced Liver Carcinogenesis in the Mouse

  2014cites this paper
• Synergism between the N-acetyltransferase 2 gene and oxidant exposure increases the risk of idiopathic male infertility.

  2014cites this paper
• Improvements in algorithms for phenotype inference: the NAT2 example.

  2014cites this paper
• Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models

  2014influential citation
• Bioactivation of the human carcinogen aristolochic acid.

  2014cites this paper
• Extrahepatic metabolism at the body's internal–external interfaces

  2014cites this paper
• Variation in N-acetyltransferase 2 (NAT2), smoking and risk of prostate cancer in the Slovak population

  2014cites this paper
• Dimethocaine, a synthetic cocaine derivative: studies on its in vitro metabolism catalyzed by P450s and NAT2.

  2014cites this paper
• Genetic unraveling of colorectal cancer

  2014cites this paper
• Structure-activity relationships and colorimetric properties of specific probes for the putative cancer biomarker human arylamine N-acetyltransferase 1.

  2014cites this paper
• ASSOCIAÇÃO DO PERFIL DE ACETILAÇÃO LENTA DO GENE NAT2 NA SUSCEPTIBILIDADE AO CÂNCER, NA REGIÃO NORTE DO BRASIL.

  2013cites this paper
• IDENTIFICATION OF GENETIC POLYMORPHISMS ASSOCIATED WITH OESOPHAGEAL SQUAMOUS CELL CARCINOMA RISK IN SOUTH AFRICA

  2013cites this paper
• THE ROLE OF THE HOXB13 GENE IN BREAST CANCER

  2013cites this paper
• Full-Gene-Sequencing Analysis of N-Acetyltransferase-2 in an Adult Indian Population

  2013influential citation
• Genetic susceptibility to asbestos and tobacco smoke related non-malignant pleuropulmonary changes

  2013cites this paper
• Clarifying haplotype ambiguity of NAT2 in multi-national cohorts.

  2013cites this paper
• Arylamine N‐acetyltransferases: a structural perspective

  2013influential citation
• Xenobiotic metabolizing enzyme activities in cells used for testing skin sensitization in vitro

  2013cites this paper
• Sex and Strain Differences in Acute Hepatotoxic and Inflammatory Responses to Liver Procarcinogens in the Developing Mouse

  2013cites this paper
• Base-displaced intercalation of the 2-amino-3-methylimidazo[4,5-f]quinolone N2-dG adduct in the NarI DNA recognition sequence

  2013cites this paper
• Polymorphisms in the Human Cytochrome P450 and Arylamine N-Acetyltransferase: Susceptibility to Head and Neck Cancers

  2013cites this paper
• Type 2 diabetes mellitus (T2DM) subjects of Bangladeshi origin with fast N-acetyltransferase 2 (NAT2) acetylator phenotype show lower insulin sensitivity than slow acetylator phenotype

  2013cites this paper
• Etude du polymorphisme génétique de la N-Acétyltransférase de type 2 dans la population sénégalaise : prévention de la toxicité et de l’échec thérapeutique de l’isoniazide dans la prise en charge de la tuberculose

  2012cites this paper
• Extrahepatic Drug-Metabolizing Enzymes and Their Significance

  2012cites this paper
• Cyanamide-mediated Inhibition of N-acetyltransferase 1.

  2012cites this paper
• High-resolution melting sequence matching screening in N-acetyltransferase 2 single nucleotide polymorphism (rs1801280 341T>C)

  2012cites this paper
• Contributions of human enzymes in carcinogen metabolism.

  2012cites this paper
• NATb/NAT1*4 promotes greater arylamine N‐acetyltransferase 1 mediated DNA adducts and mutations than NATa/NAT1*4 following exposure to 4‐aminobiphenyl

  2012influential citation
• Pharmacogenetics of Phase II Drug Metabolizing Enzymes

  2012cites this paper
• Détermination du polymorphisme d’acétylation de la N-acétyltransférase 2 dans la population sénégalaise par utilisation du test à la caféine

  2012cites this paper
• Impact of interactions of cigarette smoking with NAT2 polymorphisms on rheumatoid arthritis risk in African Americans.

  2012cites this paper
• Accuracy of various human NAT2 SNP genotyping panels to infer rapid, intermediate and slow acetylator phenotypes.

  2012cites this paper
• Tissue specificities of tumor induction by aromatic amines.

  2012cites this paper
• Antitumor Drugs and Nitrenium Ions

  2012cites this paper
• Effects of nucleotide variation on the structure and function of human arylamine n-acetyltransferase 1

  2012cites this paper
• N-Acetyltransferase 2 genotype, exfoliated urothelial cells and benzidine exposure.

  2012influential citation
• Polymorphisms in heterocyclic aromatic amines metabolism-related genes are associated with colorectal adenoma risk.

  2012cites this paper
• N-Acetylation of p-Aminobenzoic Acid and p-Phenylenediamine in Primary Porcine Urinary Bladder Epithelial Cells and in the Human Urothelial Cell Line 5637

  2012cites this paper
• No Association Between Variant N-acetyltransferase Genes, Cigarette Smoking and Prostate Cancer Susceptibility Among Men of African Descent

  2011cites this paper
• Régulation de la maturation en 3' des pré-ARNm de gènes de susceptibilité aux cancers p53 et msh6

  2011cites this paper
• Histone Deacetylase Inhibitors Increase Human Arylamine N-Acetyltransferase-1 Expression in Human Tumor Cells

  2011cites this paper
• Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic amines.

  2011cites this paper
• Genetic susceptibility to asbestos-related fibrotic pleuropulmonary changes

  2010cites this paper